Feasibility of (31)P spectroscopic imaging at 7 T in lung carcinoma patients

Currently, it is difficult to predict effective therapy response to molecular therapies for the treatment of lung cancer based solely on anatomical images. (31)P MR spectroscopic imaging could provide as a non‐invasive method to monitor potential biomarkers for early therapy evaluation, a necessity...

Descripción completa

Detalles Bibliográficos
Autores principales: van Houtum, Quincy (.Q.)., Mohamed Hoesein, Firdaus (.F.A.A.)., Verhoeff, Joost (.J.J.C.)., van Rossum, Peter (.P.S.N.)., van Lindert, Anne (.A.S.R.)., van der Velden, Tijl (.T.A.)., van der Kemp, Wybe (.W.J.M.)., Klomp, Dennis (.D.W.J.)., Arteaga de Castro, Catalina (.C.S.).
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Special Issue Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244006/
https://www.ncbi.nlm.nih.gov/pubmed/31736167
http://dx.doi.org/10.1002/nbm.4204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244006/
https://www.ncbi.nlm.nih.gov/pubmed/31736167
http://dx.doi.org/10.1002/nbm.4204

Ejemplares similares